Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva

Completed · Phase 3

Conditions studied: Lymphedema, Perioperative/Postoperative Complications, Vulvar Cancer

In brief

RATIONALE: Fibrin sealant may decrease lymphedema following surgery to remove lymph nodes in the groin by helping to seal the lymphatic vessels. It is not yet known if fibrin sealant is effective in decreasing lymphedema following surgery to remove lymph nodes. PURPOSE: Randomized phase III trial to determine the effectiveness of fibrin sealant in reducing lymphedema following surgical removal of lymph nodes in patients who have cancer of the vulva.

Key facts

Study ID

NCT00028951

Run by

Gynecologic Oncology Group

Starts

2003-01-01

Last updated by the study team

2013-07-09

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Comprehensive Cancer Center at University of Alabama at Birmingham — Birmingham, Alabama, United States
• CCOP - Western Regional, Arizona — Phoenix, Arizona, United States
• Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States
• Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center — Orange, California, United States
• University of Colorado Cancer Center at University of Colorado Health Sciences Center — Denver, Colorado, United States
• CCOP - Christiana Care Health Services — Newark, Delaware, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• MBCCOP - University of Illinois at Chicago — Chicago, Illinois, United States
• CCOP - Central Illinois — Decatur, Illinois, United States
• CCOP - Evanston — Evanston, Illinois, United States
• CCOP - Carle Cancer Center — Urbana, Illinois, United States
• Saint Joseph Regional Medical Center — South Bend, Indiana, United States
• Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
• CCOP - Michigan Cancer Research Consortium — Ann Arbor, Michigan, United States
• CCOP - Grand Rapids — Grand Rapids, Michigan, United States
• CCOP - Kalamazoo — Kalamazoo, Michigan, United States
• University of Minnesota Cancer Center — Minneapolis, Minnesota, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• CCOP - Metro-Minnesota — Saint Louis Park, Minnesota, United States
• University of Mississippi Medical Center — Jackson, Mississippi, United States
• Keesler Medical Center - Keesler Air Force Base — Keesler Air Force Base, Mississippi, United States
• Ellis Fischel Cancer Center at University of Missouri - Columbia — Columbia, Missouri, United States
• CCOP - Kansas City — Kansas City, Missouri, United States
• CCOP - Cancer Research for the Ozarks — Springfield, Missouri, United States
• CCOP - Missouri Valley Cancer Consortium — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.